… Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting
enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-…

… (ACCOMPLISH) study compared combination therapy with amlodipine/benazepril versus
hydrochlorothiazide/benazepril in 11,463 high-risk obese hypertensive patients (mean age …

… amlodipine in reducing systolic blood pressure in high-risk … adverse events in high-risk patients
compared to monotherapy … to ACE inhibitor or ARB in high-risk patients Citation[37] and it …

… reduction in blood pressure (>150 mm Hg) with a combination such as aliskiren plus amlodipine
can be … At week 24, patients received 12·5 mg hydrochlorothiazide or placebo if systolic …

… patients who are at high risk because of age, diabetes, or existing CV disease. Third, in this
patient group, an ACE inhibitor plus amlodipine … outcomes in high-risk hypertensive patients …

… GET), 25 620 patients with high-risk diabetes or … of amlodipine and benazepril significantly
reduced cardiovascular morbidity/mortality compared with the hydrochlorothiazide/benazepril …

… (an angiotensin-converting enzyme inhibitor) and amlodipine (a calcium channel … benazepril
and a thiazide diuretic in reducing cardiovascular events in high-risk hypertensive patients. …

… (CCBs) and/or hydrochlorothiazide (HCTZ) for the effective treatment of … -term medication
for hypertension. This is particularly true for high-risk patients such as the patient subgroups …

… for arterial hypertension have proposed more strict BP goals fore some high-risk patients.
Thus, … of olmesartan medoxomil/HCTZ and amlodipine besilate/benazepril were compared in …

… an ACE inhibitor plus a thiazide. There were 552 primary-outcome events in the
benazepril-amlodipine group (9.6… Benazapril plus amlodipine or hydrochlorothiazide for …